Phathom Pharmaceuticals, Inc.
PHAT
Revenue
57.58M
▲8.08M▲16.32%
3 Months ChangeAssets
259.15M
▲18.86M▲7.85%
3 Months ChangeLiabilities
697.32M
▲34.50M▲5.20%
3 Months ChangeFree Cash Flow
-84.95M
▼-15.89M▼-23.01%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001193125-26-073377
2026-01-08
Form 8-K
ID: 0001193125-26-007660
2026-01-07
Form 8-K
ID: 0001193125-26-006266
2025-11-04
Form 8-K
ID: 0001193125-25-263534
2025-10-30
Form 10-Q
ID: 0001193125-25-257390
2025-10-30
Form 8-K
ID: 0001193125-25-257382
2025-10-27
Form 8-K
ID: 0001193125-25-250611
2025-10-06
Form 8-K
ID: 0001193125-25-230984
2025-08-07
Form 10-Q
ID: 0000950170-25-104548
2025-08-07
Form 8-K
ID: 0001193125-25-174943